The EMA believes that the fourth dose of the Covid-19 vaccine is only necessary in immunocompromised patients

The European Medicines Agency has explained this Tuesday its position in relation to the reinforcement doses of the Covid-19 vaccine. The agency considers it “reasonable” that a fourth dose of the coronavirus vaccine be applied to immunosuppressed people, although it has warned that there are still no data on its application. Precisely, last week the … Read more

COVID-19: no complications during pregnancy with mRNA vaccines, reassures the EMA

Studies of pregnant women have found that the two most widely used COVID vaccines, made with messenger RNA technology, pose no risk to mothers or babies, the European Medicines Agency (EMA) said on Tuesday. ). • Read also: The COVID-19 pandemic “is far from over”, according to the boss of the WHO • Read also: … Read more

EMA: 4th dose may only be considered for immunocompromised patients – Health News

EMA’s Head of Vaccination Strategy, Marco Cavaleri, said at a press conference that drug regulators in different regions, including the EMA, “agreed that administering multiple booster doses at short intervals over time will not be a sustainable long-term solution.” Cavaleri emphasized that if revaccination is needed in the future, supplements such as vaccines for flu … Read more

EMA: “mRNA vaccines do not cause complications in pregnancies”

©  Getty Images Corona vaccines based on mRNA technology do not cause complications in pregnant women and their babies. That is what the task force COVID-19 of the European medicines agency EMA said in a statement on Tuesday. Source: BELGIAN Yesterday at 5:21 PM The task force examined several studies that focused on possible effects … Read more

The EMA insists that to protect yourself from the omicron variant of the coronavirus you have to get the third dose

The European Medicines Agency (EMA) has once again insisted that in order to protect itself from the omicron variant of the coronavirus it is necessary to receive the third dose of the vaccines. It’s Tuesday, too. European Union has confirmed that the covid passport It will stop working 9 months after you get the second … Read more

EMA lists rare spinal condition as side effect of AstraZeneca’s COVID vaccine | WORLD

Updated on 01/14/2022 10:12 am A European medicines regulator safety panel on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect to AstraZeneca’s COVID-19 vaccine. The vaccine has faced several setbacks, including production delays and probing from regulatory bodies after rare cases of serious side effects such as blood clots … Read more

EMA includes rare spinal condition as side effect of AstraZeneca’s covid vaccine

A European drug regulator safety panel on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca’s COVID-19 vaccine. The vaccine has faced several setbacks, including production delays and probing from regulatory bodies after rare cases of serious side effects such as blood clots with low platelets, prompting several … Read more

EMA includes rare spinal condition as effect of AstraZeneca’s Covid vaccine

A European medicines regulator safety panel on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect to AstraZeneca’s Covid-19 vaccine. The vaccine has faced several setbacks, including production delays and probing from regulatory bodies after rare cases of serious side effects such as blood clots with low platelets, prompting several … Read more

Preliminary studies show that the vaccine against Omikron is effective

“Although the transmission capability of the Omikron variant appears to be greater, studies from South Africa, the UK and some EU countries indicate that the risk of hospitalization with Omikron infection is lower than with the Delta variant infection,” the EMA statement said on Tuesday. The research also shows that the effectiveness of vaccines in … Read more

EMA: Initial studies support efficacy of vaccines against the omicron variant

2022-01-12 11:59 publication2022-01-12 11:59 share fot. Miguel Toro / / Shutterstock Preliminary studies confirm the effectiveness of COVID-19 vaccines in the case of infection with the omicron variant and indicate that these preparations largely protect against severe disease and hospitalization, the European Medicines Agency (EMA) reported. “Although the transmission ability of the omicron variant seems to … Read more